Eli Lilly and Co · News · TradingHolo

Eli Lilly and Co · News · TradingHolo

LLY news

Headlines tagged to this company

GLP-1 Drugs May Slow Aging By Upto Four Years, Early Research Suggest

dpa-AFX · 6 d ago

Prelude Therapeutics Teams Up With Lilly To Test Experimental Breast Cancer Drug In Phase 1 Trial

Stocktwits · 6 d ago

Walmart expands free drug coverage, adds healthcare benefits for workers

Seeking Alpha · 6 d ago

Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer

Reuters · 7 d ago

AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades

Seeking Alpha · 7 d ago

Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer

GlobeNewswire · 7 d ago

Roche signs $1.16B obesity drug deal with China’s Rona Therapeutics

Seeking Alpha · 7 d ago

Eli Lilly Price Target Maintained With a $1500.00/Share by RBC Capital

Dow Jones Newswires · 7 d ago

RBC Capital reiterates Outperform rating on Eli Lilly, $1500 price target

TradingView · 7 d ago

Eli Lilly-backed TRex Bio closes day flat after IPO

Seeking Alpha · 10 d ago

Combining Eli Lilly's Taltz with Zepbound could enhance psoriasis, metabolic benefits

Seeking Alpha · 10 d ago

Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share

Seeking Alpha · 11 d ago

PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer

Stocktwits · 11 d ago

Eli Lilly Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones Newswires · 12 d ago

Eli Lilly Stocks Jump 3.7% as $870 Million Protein Deal Expands

GuruFocus · 12 d ago

Eli Lilly Is Maintained at Overweight by Morgan Stanley

Dow Jones Newswires · 12 d ago

Lilly Stock Rises as $870 Million Gate Deal Adds One Target

GuruFocus · 13 d ago

General Medicine Raises $120M in Latest Funding Round

Dow Jones Newswires · 13 d ago

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO

Seeking Alpha · 13 d ago

General Medicine Raises $120 Mln To Build The Healthcare Store

Reuters · 13 d ago

← Previous More news →